Dyne Therapeutics, Inc. (DYN)
USD 7.48
(-9.66%)
USD 7.48
(-9.66%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -233.47 Million USD | -40.67% |
| 2022 | -164.75 Million USD | -15.36% |
| 2021 | -148.2 Million USD | -152.7% |
| 2020 | -58.34 Million USD | -302.02% |
| 2019 | -14.58 Million USD | -204.74% |
| 2018 | -4.78 Million USD | -100.5% |
| 2017 | 949 Million USD | 795.28% |
| 2016 | 106 Million USD | -85.6% |
| 2015 | 736 Million USD | 152.05% |
| 2014 | 292 Million USD | 94.67% |
| 2013 | 150 Million USD | 32.74% |
| 2012 | 113 Million USD | 107.18% |
| 2011 | -1.57 Billion USD | -314.44% |
| 2010 | 734 Million USD | 524.28% |
| 2009 | -173 Million USD | -119.18% |
| 2008 | 902 Million USD | 8.67% |
| 2007 | 830 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -68.77 Million USD | -2.2% |
| 2024 Q2 | -71.56 Million USD | -4.64% |
| 2023 Q3 | -62.27 Million USD | 6.08% |
| 2023 Q2 | -66.3 Million USD | -45.84% |
| 2023 FY | - USD | -40.21% |
| 2023 Q1 | -45.46 Million USD | -13.25% |
| 2023 Q4 | -67.12 Million USD | -7.79% |
| 2022 Q3 | -41.88 Million USD | 19.91% |
| 2022 FY | - USD | -15.36% |
| 2022 Q4 | -40.14 Million USD | 4.14% |
| 2022 Q1 | -35.32 Million USD | 31.33% |
| 2022 Q2 | -52.29 Million USD | -48.03% |
| 2021 Q3 | -42.32 Million USD | -42.47% |
| 2021 FY | - USD | -152.7% |
| 2021 Q4 | -51.44 Million USD | -21.56% |
| 2021 Q2 | -29.7 Million USD | -20.12% |
| 2021 Q1 | -24.73 Million USD | 13.53% |
| 2020 Q2 | -8.69 Million USD | -13.26% |
| 2020 Q1 | -7.67 Million USD | -46.07% |
| 2020 Q3 | -13.61 Million USD | -56.55% |
| 2020 FY | - USD | -302.02% |
| 2020 Q4 | -28.6 Million USD | -110.06% |
| 2019 Q3 | -5.76 Million USD | -145.24% |
| 2019 Q1 | -2.35 Million USD | 0.0% |
| 2019 FY | - USD | -204.74% |
| 2019 Q4 | -5.25 Million USD | 8.86% |
| 2019 Q2 | -2.35 Million USD | 0.0% |
| 2018 FY | - USD | -100.5% |
| 2017 FY | - USD | 795.28% |
| 2017 Q4 | -1.39 Billion USD | -723.21% |
| 2017 Q3 | 224 Million USD | 115.38% |
| 2017 Q2 | 104 Million USD | -92.05% |
| 2017 Q1 | 1.3 Billion USD | 500.0% |
| 2016 Q1 | 343 Million USD | 234.51% |
| 2016 Q2 | -497 Million USD | -244.9% |
| 2016 Q3 | 99 Million USD | 119.92% |
| 2016 Q4 | 218 Million USD | 120.2% |
| 2016 FY | - USD | -85.6% |
| 2015 FY | - USD | 152.05% |
| 2015 Q4 | -255 Million USD | -181.21% |
| 2015 Q3 | 314 Million USD | 66.14% |
| 2015 Q2 | 189 Million USD | 1081.25% |
| 2015 Q1 | 16 Million USD | -88.15% |
| 2014 Q1 | 78 Million USD | 333.33% |
| 2014 Q4 | 135 Million USD | 48.35% |
| 2014 Q3 | 91 Million USD | 4650.0% |
| 2014 Q2 | -2 Million USD | -102.56% |
| 2014 FY | - USD | 94.67% |
| 2013 Q3 | 144 Million USD | 1409.09% |
| 2013 Q4 | 18 Million USD | -87.5% |
| 2013 FY | - USD | 32.74% |
| 2013 Q1 | -1 Million USD | -100.1% |
| 2013 Q2 | -11 Million USD | -1000.0% |
| 2012 Q4 | 970 Million USD | 758.41% |
| 2012 Q3 | 113 Million USD | 111.21% |
| 2012 FY | - USD | 107.18% |
| 2012 Q2 | -1 Billion USD | -3460.0% |
| 2012 Q1 | 30 Million USD | 101.77% |
| 2011 Q3 | 66 Million USD | 925.0% |
| 2011 Q1 | 202 Million USD | -40.41% |
| 2011 Q2 | -8 Million USD | -103.96% |
| 2011 Q4 | -1.69 Billion USD | -2672.73% |
| 2011 FY | - USD | -314.44% |
| 2010 Q1 | 248 Million USD | 6300.0% |
| 2010 Q4 | 339 Million USD | 123.03% |
| 2010 FY | - USD | 524.28% |
| 2010 Q3 | 152 Million USD | -32.39% |
| 2010 Q2 | 224.8 Million USD | -9.35% |
| 2009 Q1 | 294 Million USD | 18.07% |
| 2009 Q4 | -4 Million USD | -103.28% |
| 2009 FY | - USD | -119.18% |
| 2009 Q3 | 122 Million USD | 131.69% |
| 2009 Q2 | -385 Million USD | -230.95% |
| 2008 Q4 | 249 Million USD | -36.15% |
| 2008 FY | - USD | 8.67% |
| 2008 Q1 | 147 Million USD | 36.11% |
| 2008 Q2 | 116 Million USD | -21.09% |
| 2008 Q3 | 390 Million USD | 236.21% |
| 2007 Q3 | 371 Million USD | 70.18% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | 108 Million USD | -70.89% |
| 2007 Q2 | 218 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -21.502% |
| Alkermes plc | 495.04 Million USD | 147.162% |
| Agenus Inc. | -145.92 Million USD | -59.998% |
| Aptorum Group Limited | -9.59 Million USD | -2332.296% |
| Ardelyx, Inc. | -55.35 Million USD | -321.787% |
| Dyadic International, Inc. | -8.22 Million USD | -2736.979% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -80132.302% |
| Lantern Pharma Inc. | -15.78 Million USD | -1378.942% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -1072.516% |
| Novavax, Inc. | -487.39 Million USD | 52.097% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -228.728% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -197.448% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -1199.005% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -2242.255% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -306.923% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 38.554% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -868.302% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 44235.35% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -48.526% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -212.072% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1058.173% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -883.678% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -912.56% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -91.212% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | 9.59% |
| AlloVir, Inc. | -190.14 Million USD | -22.788% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -32.905% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -697.99% |
| Bicycle Therapeutics plc | -183.4 Million USD | -27.304% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -41.14% |
| ChromaDex Corporation | -3.89 Million USD | -5895.788% |
| Chimerix, Inc. | -92.97 Million USD | -151.12% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -425.413% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -107.472% |
| CRISPR Therapeutics AG | -202.7 Million USD | -15.182% |
| Precision BioSciences, Inc. | -32.04 Million USD | -628.656% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -35.561% |
| Fortress Biotech, Inc. | -133.64 Million USD | -74.701% |
| Fortress Biotech, Inc. | -133.64 Million USD | -74.701% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -201.871% |
| ImmuCell Corporation | -2.5 Million USD | -9223.835% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -79.017% |
| Immix Biopharma, Inc. | -16.13 Million USD | -1346.958% |
| Incyte Corporation | 919.42 Million USD | 125.394% |
| Innoviva, Inc. | 248.96 Million USD | 193.781% |
| IO Biotech, Inc. | -91.22 Million USD | -155.926% |
| Jaguar Health, Inc. | -33.13 Million USD | -604.706% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -53.424% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 329.512% |
| ContextLogic Inc. | -324 Million USD | 27.94% |
| MiMedx Group, Inc. | 40.51 Million USD | 676.242% |
| MEI Pharma, Inc. | 26.38 Million USD | 985.049% |
| NextCure, Inc. | -59.03 Million USD | -295.461% |
| Onconetix, Inc. | -36.7 Million USD | -536.058% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 10546.353% |
| Opthea Limited | -200.01 Million USD | -16.727% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -8385.161% |
| Vaxcyte, Inc. | -464.88 Million USD | 49.778% |
| PDS Biotechnology Corporation | -40.08 Million USD | -482.453% |
| Precigen, Inc. | -89.22 Million USD | -161.668% |
| Pharming Group N.V. | 9.87 Million USD | 2463.835% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -46.795% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -925.727% |
| PureTech Health plc | -11.62 Million USD | -1908.05% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -1274.925% |
| Avidity Biosciences, Inc. | -233.49 Million USD | 0.009% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -868.302% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -167.053% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -706.118% |
| Acelyrin, Inc. | -381.52 Million USD | 38.805% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -1811913.917% |
| Summit Therapeutics Inc. | 1 Million USD | 23424.276% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -599.323% |
| Senti Biosciences, Inc. | -61.33 Million USD | -280.651% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -107.896% |
| Elevation Oncology, Inc. | -41.46 Million USD | -463.04% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -655.488% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -3717.122% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -72633.956% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -619.428% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -2680.8% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -297.136% |
| Seer, Inc. | -97.88 Million USD | -138.521% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -275.381% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -257.188% |
| ESSA Pharma Inc. | -26.45 Million USD | -782.53% |
| GlycoMimetics, Inc. | -39.12 Million USD | -496.79% |
| GT Biopharma, Inc. | 5.97 Million USD | 4004.934% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -12.958% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -3299.476% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 368.944% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -311.382% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -355.839% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -2261.467% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 56.758% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -3291.575% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -398.22% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | 1.33% |
| Aptose Biosciences Inc. | -52.26 Million USD | -346.69% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -116.696% |
| Soligenix, Inc. | -7.85 Million USD | -2873.137% |
| Century Therapeutics, Inc. | -121.2 Million USD | -92.624% |
| Kura Oncology, Inc. | -164.95 Million USD | -41.539% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -191.488% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -2214.852% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -24277.832% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -5318.334% |
| Autolus Therapeutics plc | -156.77 Million USD | -48.929% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -175.791% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -238.366% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -1071.245% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -23.354% |
| GRI Bio, Inc. | -10.89 Million USD | -2042.375% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -5070.3% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -90.583% |
| IGM Biosciences, Inc. | -253.35 Million USD | 7.847% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -124.946% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -512.264% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -1422.911% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -1383.024% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -310.724% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -117.992% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 12.226% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -20.386% |
| Verastem, Inc. | -83.16 Million USD | -180.735% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -361.67% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -47.557% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -104.644% |
| Histogen Inc. | -10.5 Million USD | -2122.946% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -1535.019% |
| Surrozen, Inc. | -41.13 Million USD | -467.64% |
| Organovo Holdings, Inc. | -14.8 Million USD | -1476.901% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 7280299.563% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -297.655% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -355.172% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -983.969% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -2700.142% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -40.592% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -373.981% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -866.134% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -1450.816% |
| Apollomics, Inc. | -171.74 Million USD | -35.942% |
| Amarin Corporation plc | -50.9 Million USD | -358.682% |
| Mesoblast Limited | -61.33 Million USD | -280.682% |
| Turnstone Biologics Corp. | -56.23 Million USD | -315.187% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -63.041% |
| Synaptogenix, Inc. | -8.3 Million USD | -2710.422% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -1422.107% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -270.321% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4772.747% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 54518.363% |
| Exelixis, Inc. | 196.6 Million USD | 218.756% |
| Better Therapeutics, Inc. | -38.26 Million USD | -510.203% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -65.107% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 52.853% |
| NLS Pharmaceutics AG | -11.79 Million USD | -1879.339% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 94542.107% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -691.283% |
| Gritstone bio, Inc. | -126.86 Million USD | -84.038% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -259.277% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -5736.979% |
| Avid Bioservices, Inc. | -11.48 Million USD | -1933.586% |
| Insmed Incorporated | -654.73 Million USD | 64.341% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -10278.007% |
| MediWound Ltd. | -4.89 Million USD | -4671.633% |
| OmniAb, Inc. | -49.73 Million USD | -369.478% |
| Alector, Inc. | -142.89 Million USD | -63.393% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -173.282% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -347.718% |
| Zai Lab Limited | -366.57 Million USD | 36.308% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 19.667% |
| Aura Biosciences, Inc. | -83.69 Million USD | -178.957% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -3.652% |
| Immunic, Inc. | -99.11 Million USD | -135.568% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -77.319% |
| Veracyte, Inc. | -49.4 Million USD | -372.537% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -3205.185% |
| FibroGen, Inc. | -261.4 Million USD | 10.684% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -1995.647% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -3234.739% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -1147.41% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 116.108% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -818.401% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 685.3% |
| TG Therapeutics, Inc. | 26.1 Million USD | 994.544% |
| Galecto, Inc. | -37.51 Million USD | -522.287% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -510.155% |
| Fortrea Holdings Inc. | 167.3 Million USD | 239.555% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -73.873% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -724.683% |
| XBiotech Inc. | -35.76 Million USD | -552.788% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -259.277% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -257.818% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -123.518% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -809.458% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -471.307% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 54.792% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -316.765% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -416442.078% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -100.693% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -953.138% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | 0.676% |
| NexImmune, Inc. | -28.16 Million USD | -728.884% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -4125.391% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -1879.907% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 105.016% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -819.486% |
| Scopus BioPharma Inc. | -11.71 Million USD | -1893.281% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -85.525% |
| Ainos, Inc. | -8.77 Million USD | -2561.272% |
| Pluri Inc. | -20.22 Million USD | -1054.393% |
| Prothena Corporation plc | -190.1 Million USD | -22.812% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -82.121% |
| Celularity Inc. | -183.94 Million USD | -26.926% |
| Rallybio Corporation | -72.37 Million USD | -222.601% |
| Cue Biopharma, Inc. | -46.05 Million USD | -406.983% |
| MeiraGTx Holdings plc | -57.05 Million USD | -309.234% |
| Omeros Corporation | -163.61 Million USD | -42.703% |
| Humacyte, Inc. | -96.45 Million USD | -142.049% |
| Immunocore Holdings plc | -59.64 Million USD | -291.416% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -1105.224% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -858.243% |
| Blueprint Medicines Corporation | -474.61 Million USD | 50.807% |
| CalciMedica, Inc. | -34.18 Million USD | -582.898% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -218.808% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -86.041% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -38.602% |
| Sana Biotechnology, Inc. | -252.39 Million USD | 7.494% |
| Pulmatrix, Inc. | -12.64 Million USD | -1746.244% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -608.233% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -163.913% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 53.887% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -130.673% |
| Cytokinetics, Incorporated | -456.68 Million USD | 48.876% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -599.595% |
| Nutriband Inc. | -5.12 Million USD | -4458.496% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -439.554% |
| Vor Biopharma Inc. | -114.37 Million USD | -104.139% |
| Roivant Sciences Ltd. | -996.51 Million USD | 76.571% |
| Evogene Ltd. | -23.2 Million USD | -906.189% |
| ProKidney Corp. | -147.66 Million USD | -58.108% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -261.782% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -152350.228% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 58.711% |
| CorMedix Inc. | -48.88 Million USD | -377.583% |
| BioLineRx Ltd. | -57.06 Million USD | -309.169% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -108.912% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -115482.178% |
| Atai Life Sciences N.V. | -36.31 Million USD | -542.99% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -193.618% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -187.132% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 15.255% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -659.519% |
| MediciNova, Inc. | -9.87 Million USD | -2263.125% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -85.385% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -15157.865% |
| GeoVax Labs, Inc. | -26.66 Million USD | -775.466% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -3.771% |
| Biomea Fusion, Inc. | -124.62 Million USD | -87.35% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 29.323% |
| Mereo BioPharma Group plc | -26.05 Million USD | -796.055% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -22.663% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -1.537% |
| Absci Corporation | -95.45 Million USD | -144.588% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -677.605% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -117.962% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -921.553% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -12.337% |
| Allakos Inc. | -189.91 Million USD | -22.937% |
| Imunon, Inc. | -19.87 Million USD | -1074.528% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -115.201% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 315.535% |
| BioAtla, Inc. | -122.24 Million USD | -90.996% |
| NLS Pharmaceutics AG | -11.79 Million USD | -1879.339% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -1381.353% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 22.251% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -463.312% |
| XOMA Corporation | -39.36 Million USD | -493.151% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -135.231% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -98.45% |
| aTyr Pharma, Inc. | -52.17 Million USD | -347.461% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -178.561% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -57.084% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | 0.464% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -1610.071% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -2803.1% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1289.573% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 123824.736% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 151.66% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -3554.558% |
| UroGen Pharma Ltd. | -63.83 Million USD | -265.772% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -243.777% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -3114.589% |
| Orgenesis Inc. | -60.71 Million USD | -284.525% |
| Entera Bio Ltd. | -8.8 Million USD | -2551.931% |
| GH Research PLC | -41.15 Million USD | -467.337% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -814.91% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -183.92% |
| Xencor, Inc. | -125.87 Million USD | -85.484% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -16266.536% |
| Replimune Group, Inc. | -230.19 Million USD | -1.424% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -1058.252% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -2033.76% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -3554.558% |
| Portage Biotech Inc. | -18.19 Million USD | -1182.906% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -15157.865% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -123.243% |
| OncoCyte Corporation | -23.12 Million USD | -909.713% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -1966.093% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -1937.874% |
| Purple Biotech Ltd. | -22.22 Million USD | -950.511% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -3542.371% |
| scPharmaceuticals Inc. | -46.06 Million USD | -406.884% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -1210.95% |
| HilleVax, Inc. | -132.46 Million USD | -76.254% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -2095.768% |
| Tharimmune, Inc. | -9.3 Million USD | -2409.796% |
| Genprex, Inc. | -31.06 Million USD | -651.68% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -24.503% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -644.645% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -30459.686% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 154818.231% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1482676.118% |
| Savara Inc. | -59.13 Million USD | -294.832% |
| Curis, Inc. | -45.13 Million USD | -417.238% |
| Daré Bioscience, Inc. | -30.7 Million USD | -660.471% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -1436.921% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -3158.562% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -773.33% |
| BeiGene, Ltd. | -1.12 Billion USD | 79.239% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -1332.263% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 45.777% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -158.441% |
| Erasca, Inc. | -121.31 Million USD | -92.462% |
| bluebird bio, Inc. | -167.16 Million USD | -39.671% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -5089.79% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 175.246% |
| DBV Technologies S.A. | -85.98 Million USD | -171.541% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -5089.79% |
| Moderna, Inc. | -3.28 Billion USD | 92.888% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -447.95% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -4033.782% |
| Molecular Templates, Inc. | 1.43 Million USD | 16426.993% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -290.089% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 28.436% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -70.31% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -392.919% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -67.927% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -13.415% |
| MacroGenics, Inc. | 2.01 Million USD | 11675.409% |
| RenovoRx, Inc. | -11.39 Million USD | -1949.833% |
| Adicet Bio, Inc. | -136.53 Million USD | -71.001% |
| Prime Medicine, Inc. | -193.75 Million USD | -20.498% |
| Aditxt, Inc. | -25.45 Million USD | -817.104% |
| Adagene Inc. | -14.95 Million USD | -1461.63% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3093.883% |
| Quantum-Si incorporated | -91.8 Million USD | -154.32% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 132.773% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 284.632% |
| SciSparc Ltd. | -5.28 Million USD | -4320.22% |
| Vericel Corporation | 2.86 Million USD | 8252.095% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -245127.292% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -976.351% |
| Generation Bio Co. | -133.3 Million USD | -75.151% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -181.195% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -171.411% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -2.657% |
| Invivyd, Inc. | -196.61 Million USD | -18.748% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 37.599% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -2417.316% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 959.822% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -2170.063% |
| 2seventy bio, Inc. | -206.41 Million USD | -13.108% |
| ADMA Biologics, Inc. | 5.12 Million USD | 4660.078% |
| Clene Inc. | -43.24 Million USD | -439.941% |
| Capricor Therapeutics, Inc. | -23 Million USD | -914.717% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -381.622% |
| GeoVax Labs, Inc. | -26.66 Million USD | -775.466% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 22.062% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -535.666% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1090.438% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 4854.865% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -618.786% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -47.393% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 65.881% |
| Evaxion Biotech A/S | -21.4 Million USD | -990.856% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -251.541% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -7.262% |
| Trevena, Inc. | -35.28 Million USD | -561.63% |
| Surrozen, Inc. | -41.13 Million USD | -467.64% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -193.341% |
| Cingulate Inc. | -22.95 Million USD | -917.235% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -3029.286% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -526.226% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -2738.141% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -128.303% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -244.223% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -299.979% |
| Clearmind Medicine Inc. | -8.71 Million USD | -2580.347% |
| Kronos Bio, Inc. | -121.83 Million USD | -91.641% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -214.057% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -9463.147% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -131.561% |
| Statera Biopharma, Inc. | 38.93 Million USD | 699.657% |
| ImmunityBio, Inc. | -436.18 Million USD | 46.473% |
| Korro Bio, Inc. | -80.9 Million USD | -188.584% |
| Kineta, Inc. | -15.71 Million USD | -1385.783% |
| BioVie Inc. | -31.95 Million USD | -630.75% |
| Codexis, Inc. | -49.28 Million USD | -373.746% |
| Celularity Inc. | -183.94 Million USD | -26.926% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -5.402% |
| Celcuity Inc. | -58.3 Million USD | -300.405% |
| Virax Biolabs Group Limited | -6.6 Million USD | -3432.621% |
| Cibus, Inc. | -314.58 Million USD | 25.783% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -592.129% |
| IN8bio, Inc. | -28.5 Million USD | -719.099% |
| Kodiak Sciences Inc. | -259.02 Million USD | 9.863% |
| Annexon, Inc. | -141.57 Million USD | -64.913% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -107.352% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -263.692% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -735.185% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -1.507% |
| Eyenovia, Inc. | -24.1 Million USD | -868.538% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 621.338% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -71960.494% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -216.346% |
| Arcellx, Inc. | -64.14 Million USD | -263.982% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -418.674% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -89.086% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -656.026% |
| Moolec Science SA | -52.07 Million USD | -348.341% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -352.42% |
| Geron Corporation | -174.78 Million USD | -33.581% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -477.668% |
| Royalty Pharma plc | 1.88 Billion USD | 112.371% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -95.225% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -2403.964% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1025.687% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -40.58% |
| Humacyte, Inc. | -96.45 Million USD | -142.049% |
| Structure Therapeutics Inc. | -102.45 Million USD | -127.873% |
| 89bio, Inc. | -134.46 Million USD | -73.636% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -196.008% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 5861.994% |
| Genelux Corporation | -24.16 Million USD | -866.174% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -590.757% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -42.83% |
| Notable Labs, Ltd. | -14.4 Million USD | -1521.361% |
| Liquidia Corporation | -70.05 Million USD | -233.294% |
| Mustang Bio, Inc. | -48.06 Million USD | -385.771% |
| Immunovant, Inc. | -269.97 Million USD | 13.52% |
| Quantum-Si incorporated | -91.8 Million USD | -154.32% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -228.904% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -1109.219% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -128.871% |
| Acasti Pharma Inc. | -11.3 Million USD | -1965.976% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -949.177% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -1422.911% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -10.908% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -5367.383% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -1370.252% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -711.357% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -530.505% |
| PepGen Inc. | -83.58 Million USD | -179.338% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -691.337% |
| United Therapeutics Corporation | 1.38 Billion USD | 116.836% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -919.679% |
| Solid Biosciences Inc. | -93.43 Million USD | -149.883% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -4792.894% |
| Immuneering Corporation | -58.06 Million USD | -302.123% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 7280299.563% |
| Silo Pharma, Inc. | -3.62 Million USD | -6338.561% |
| Belite Bio, Inc | -31.52 Million USD | -640.512% |
| XOMA Corporation | -39.36 Million USD | -493.151% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -246.162% |
| Bionomics Limited | -9.83 Million USD | -2273.448% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -177.997% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -574.669% |
| uniQure N.V. | -253.1 Million USD | 7.753% |
| Cassava Sciences, Inc. | -95.68 Million USD | -144.0% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3093.883% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -80.285% |
| Forte Biosciences, Inc. | -32.47 Million USD | -618.896% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -2800.153% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -727.372% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -71960.494% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -1995.647% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -1368.31% |
| Altimmune, Inc. | -87.93 Million USD | -165.51% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -153.561% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -574.669% |
| Compugen Ltd. | -12.51 Million USD | -1765.42% |
| Peak Bio, Inc. | -1356.23 USD | -17214974.139% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -380.423% |
| Benitec Biopharma Inc. | -22.49 Million USD | -938.133% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 3.643% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -717.98% |
| Zura Bio Limited | -60.56 Million USD | -285.509% |
| PolyPid Ltd. | -20.26 Million USD | -1052.228% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -1395.395% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -717.98% |
| Instil Bio, Inc. | -146.12 Million USD | -59.782% |
| argenx SE | -216.02 Million USD | -8.079% |
| Immunome, Inc. | -28.27 Million USD | -725.85% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -381.662% |
| Verona Pharma plc | -52.46 Million USD | -344.991% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -146.355% |
| Shattuck Labs, Inc. | -87.61 Million USD | -166.479% |
| CervoMed Inc. | -2.17 Million USD | -10649.979% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -90.992% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -1739.408% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -384.651% |
| Moolec Science SA | -52.07 Million USD | -348.341% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -1262.172% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -79.058% |
| AnaptysBio, Inc. | -143.16 Million USD | -63.083% |
| Design Therapeutics, Inc. | -66.32 Million USD | -252.018% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -188.288% |
| NeurAxis, Inc. | -6.66 Million USD | -3403.281% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -518.479% |
| Lumos Pharma, Inc. | -36.57 Million USD | -538.436% |
| Achilles Therapeutics plc | -70.44 Million USD | -231.444% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -146.355% |
| 180 Life Sciences Corp. | -22.13 Million USD | -954.828% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 4105.251% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -9463.147% |
| Nutriband Inc. | -5.12 Million USD | -4458.496% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -112.738% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -321.194% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -361.871% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -257.67% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -331.485% |
| Palisade Bio, Inc. | -12.28 Million USD | -1801.116% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -414.536% |
| Beam Therapeutics Inc. | -156.47 Million USD | -49.212% |
| Neurogene Inc. | -52.28 Million USD | -346.536% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -71.057% |
| AEON Biopharma, Inc. | -48.36 Million USD | -382.777% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -151.001% |
| Sesen Bio, Inc. | -50.84 Million USD | -359.237% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -184.963% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -1790.49% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 45.377% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -121.942% |
| Athira Pharma, Inc. | -116.7 Million USD | -100.06% |
| Vaccinex, Inc. | -19.74 Million USD | -1082.277% |
| HCW Biologics Inc. | -23.57 Million USD | -890.31% |
| XOMA Corporation | -39.36 Million USD | -493.151% |
| Nektar Therapeutics | -243.1 Million USD | 3.962% |
| Arvinas, Inc. | -394.8 Million USD | 40.862% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 123824.736% |
| Merus N.V. | -149.2 Million USD | -56.478% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -149.734% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -646.884% |
| Rezolute, Inc. | -68.42 Million USD | -241.224% |
| Clene Inc. | -43.24 Million USD | -439.941% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1413.897% |
| BeyondSpring Inc. | -21.54 Million USD | -983.918% |
| Synlogic, Inc. | -55.16 Million USD | -323.263% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -1832.268% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -2093.911% |
| Peak Bio, Inc. | -1356.23 USD | -17214974.139% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -619.162% |
| Krystal Biotech, Inc. | 17.9 Million USD | 1404.044% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -97.154% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 31.601% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -4968.478% |
| MannKind Corporation | 15.12 Million USD | 1643.235% |
| Ikena Oncology, Inc. | -74.39 Million USD | -213.824% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -1754.014% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 1248.6% |
| Gossamer Bio, Inc. | -172.15 Million USD | -35.622% |
| CohBar, Inc. | -12.06 Million USD | -1835.03% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -815.269% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -677.605% |
| Legend Biotech Corporation | -477.87 Million USD | 51.143% |
| Mural Oncology plc | -192.72 Million USD | -21.148% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -104.707% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -1346.095% |
| Disc Medicine, Inc. | -91.02 Million USD | -156.497% |
| Champions Oncology, Inc. | -5.05 Million USD | -4519.628% |
| REGENXBIO Inc. | -239.46 Million USD | 2.501% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -2078.316% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -318.746% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -502.235% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -106.971% |
| Vaxart, Inc. | -74.72 Million USD | -212.455% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -563.128% |
| Cellectis S.A. | -98.09 Million USD | -138.01% |
| Longeveron Inc. | -20.06 Million USD | -1063.888% |
| Repare Therapeutics Inc. | -114.27 Million USD | -104.314% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 46.84% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -212.084% |
| Revolution Medicines, Inc. | -430.58 Million USD | 45.777% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -3612.45% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -658.31% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -213.012% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 4861.901% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -2029.284% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 105.07% |
| Denali Therapeutics Inc. | -179.97 Million USD | -29.728% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -245127.292% |
| Veru Inc. | -89.97 Million USD | -159.488% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -768.651% |
| Cingulate Inc. | -22.95 Million USD | -917.235% |
| Passage Bio, Inc. | -98.34 Million USD | -137.415% |
| Context Therapeutics Inc. | -25.06 Million USD | -831.647% |
| Exicure, Inc. | -15.53 Million USD | -1402.516% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -13.303% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -531.426% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -3815.677% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -38.591% |
| Nuvalent, Inc. | -149.49 Million USD | -56.18% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -2770.931% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -171.819% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -673.663% |
| OmniAb, Inc. | -49.73 Million USD | -369.478% |
| Anew Medical, Inc. | -1.3 Million USD | -17848.095% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -1788.353% |
| Lipocine Inc. | -16.32 Million USD | -1330.379% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -250.196% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -214.221% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -512.264% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -498.442% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -952.5% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 57.166% |
| Ocugen, Inc. | -64.82 Million USD | -260.152% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -152.216% |
| Q32 Bio Inc. | -86.5 Million USD | -169.908% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -1279.311% |
| Alumis Inc. Common Stock | -156.89 Million USD | -48.815% |
| Equillium, Inc. | -12.13 Million USD | -1823.513% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -299.295% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -2854.14% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1137.879% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -400.034% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -119.546% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -1205.313% |
| Dominari Holdings Inc. | -22.44 Million USD | -940.446% |
| Edesa Biotech, Inc. | -8.19 Million USD | -2750.695% |
| vTv Therapeutics Inc. | -25.41 Million USD | -818.763% |
| Bio-Techne Corporation | 326.66 Million USD | 171.473% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 39.335% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 207.896% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -78.079% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -523.75% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -54.517% |
| Nkarta, Inc. | -120.48 Million USD | -93.787% |
| BioCardia, Inc. | -11.56 Million USD | -1919.689% |
| Iterum Therapeutics plc | -34.58 Million USD | -575.176% |